Literature DB >> 3102218

Effect of sodium valproate on psychomotor performance in children as a function of dose, fluctuations in concentration, and diagnosis.

M G Aman, J S Werry, J W Paxton, S H Turbott.   

Abstract

Forty-six children receiving sodium valproate monotherapy, and with well-controlled seizures, were tested three times, at weekly intervals in the morning, on an extensive battery of psychomotor tests. The first session was a practice session to minimize subsequent practice effects. On one of the remaining 2 test days, morning medication was delayed until after testing (low concentration condition), whereas sodium valproate was given before testing on the alternate session (high concentration day). The data were analyzed for the effects of diagnosis (partial vs. generalized epilepsy), dose (above or below 20 mg/kg/day), and time of medication (low and high drug concentration days). Four variables discriminated between the diagnostic groups, all favoring children with generalized epilepsy. Another four measures were significantly associated with dose, with those on lower doses performing at a superior level. Time of medication had virtually no effect on performance, however. The findings were related to previous diagnostic and dosage research. Although a deterioration in performance at higher doses appears to be consistent with other dosage research, the absence of an effect due to time of medication suggests that performance does not fluctuate between drug administrations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3102218     DOI: 10.1111/j.1528-1157.1987.tb03636.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  5 in total

Review 1.  A comparative review of the adverse effects of anticonvulsants in children with epilepsy.

Authors:  S J Wallace
Journal:  Drug Saf       Date:  1996-12       Impact factor: 5.606

2.  Transport of valproate and its effects on GABA uptake in astroglial primary culture.

Authors:  M Nilsson; E Hansson; L Rönnbäck
Journal:  Neurochem Res       Date:  1990-08       Impact factor: 3.996

3.  Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders.

Authors:  Michael G Aman; Alexander A Vinks; Bart Remmerie; Erik Mannaert; Yaser Ramadan; Jessica Masty; Ronald L Lindsay; Krista Malone
Journal:  Clin Ther       Date:  2007-07       Impact factor: 3.393

4.  Fenfluramine and methylphenidate in children with mental retardation and attention deficit hyperactivity disorder: laboratory effects.

Authors:  M G Aman; R A Kern; D E McGhee; L E Arnold
Journal:  J Autism Dev Disord       Date:  1993-09

5.  Parents' Subjective Assessment of Effects of Antiepileptic Drug Discontinuation.

Authors:  Gun-Ha Kim; Jung Hye Byeon; So-Hee Eun; Baik-Lin Eun
Journal:  J Epilepsy Res       Date:  2015-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.